Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Bayer
AstraZeneca
Washington University School of Medicine
Indiana University
GlaxoSmithKline
M.D. Anderson Cancer Center
Indiana University
Memorial Sloan Kettering Cancer Center
IDRx Inc. - A GSK Company
M.D. Anderson Cancer Center
British Columbia Cancer Agency
Turning Point Therapeutics, Inc.
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Cedars-Sinai Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
Peking University
Theseus Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Aesculap AG
Stanford University
Fred Hutchinson Cancer Center
Cambridge University Hospitals NHS Foundation Trust
Oregon Health and Science University
Virginia Commonwealth University
Yale University
Stanford University
Takeda
Novartis
Unity Health Toronto
Stanford University
Pfizer
Exelixis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Poniard Pharmaceuticals
FeRx